Skip to main content
SpringerLink
Log in

Aspetti che influenzano l’adesione alla terapia

  • Chapter
Aspetti psicologici nella sclerosi multipla

  • 419 Accesses

Riassunto

Tra le diverse possibili modalità d’interazione di due esseri umani, quella che lega medico e paziente nel rapporte di cura è sicuramente la più peculiare. In essa, l’amministrazione di un bene irrinunciabile (la salute) è affidata a un professionista che interagisce e comunica con il paziente, da cui riceve utili informazioni e spunti per costituire la successiva alleanza terapeutica.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Letture consigliate

  • Bonino S (2006) Mille fili mi legano qui. Laterza, Roma

    Google Scholar 

  • Conrad P (1985) The meaning of medications: another look at compliance. Soc Sci Med 20:29–37

    Article  PubMed  Google Scholar 

  • Cosmacini G (1995) La qualità del tuo medico. Editori Laterza, Bari-Roma

    Google Scholar 

  • Devonshire V, Lapierre Y, Macdonell R et al; GAP Study Group (2011) The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis. Eur J Neurol 18(1):69–77

    Article  PubMed  Google Scholar 

  • Ghetti V (1995) La partecipazione del paziente al suo trattamento. Compliance e non compliance. Franco Angeli, Milano

    Google Scholar 

  • Haynes RB, Taylor DW, Sackett DL et al (1979) Compliance in health care. John Hopkins University Press, Baltimore

    Google Scholar 

  • Minden SL, Moes EJ, Orav J et al (1990) Memory impairment in multiple sclerosis. J Clin Exp Neuropsychol 12:566–586

    Article  PubMed  Google Scholar 

  • Mohr DC, Goodkin DE, Likosky W et al (1996) Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment. Mult Scler 2:222–226

    PubMed  Google Scholar 

  • Mohr DC, Goodkin DE, Likosky W et al (1997) Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 54:531–533

    Article  PubMed  Google Scholar 

  • Moja A, Vegni E (1997) La comunicazione e la relazione fra medico e paziente nella medicina patient centered. In: Cesa Bianchi M (ed) Ricerche di psicologia. Franco Angeli, Milano, pp. 441–452

    Google Scholar 

  • Osteberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487–497

    Article  Google Scholar 

  • Patti F (2009) Cognitive impairment in multiple sclerosis. Mult Scler 15(1):2–8

    Article  PubMed  Google Scholar 

  • Patti F (2010) Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence. Patient Prefer Adherence 4:1–9

    Article  PubMed  Google Scholar 

  • Patti F, Amato MP, Trojano M et al; COGIMUS Study Group (2009) Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 15(7):779–788

    Article  PubMed  Google Scholar 

  • Portaccio E, Zipoli V, Siracusa G et al (2008) Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis. Eur Neurol 59:131–135

    Article  PubMed  Google Scholar 

  • Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41:685–691

    Article  PubMed  Google Scholar 

  • Rio J, Porcel J, Téllez N et al (2005) Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis. Mult Scler 11:306–309

    Article  PubMed  Google Scholar 

  • Sadovnick AD, Remick RA, Allen J et al (1996) Depression and multiple sclerosis. Neurology 46:628–632

    Article  PubMed  Google Scholar 

  • Solari A, Mattarozzi K, Vignatelli L et al; SIMS-Trial group; GERONIMUS group (2010) Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. Mult Scler 16(10):1237–1247

    Article  PubMed  Google Scholar 

  • Tremlett HL, Oger J (2003) Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS. Neurology 61:551–554

    Article  PubMed  Google Scholar 

  • Zani B, Selleri P (1995) Il modello dialogico. In: Zani B, Selleri P, David D (eds) La comunicazione. Ed NIS, Roma, pp. 21–22

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Sclerosi Multipla, Policlinico “G. Rodolico” Università di Catania, Catania, Italia

    F. Patti

Authors
  1. F. Patti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Cilia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Patti .

Editor information

Editors and Affiliations

  1. Onorario di Psicologia dello Sviluppo e dell’Educazione Dipartimento di Psicologia, Università di Torino, Italia

    Silvia Bonino (Professore) (Professore)

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Patti, F., Cilia, S. (2013). Aspetti che influenzano l’adesione alla terapia. In: Bonino, S. (eds) Aspetti psicologici nella sclerosi multipla. Springer, Milano. https://doi.org/10.1007/978-88-470-2724-4_8

Download citation

Publish with us

Policies and ethics

Search

Navigation